László Offertáler

Statistics

Publications

Citations

2.9K

H-Index

Active since

2002

Affiliations

National Institute on Alcohol Abuse and Alcoholism(Current)

National Institutes of Health

University of Washington

László Offertáler is an author at National Institute on Alcohol Abuse and Alcoholism specializing in pharmacology, cannabinoid pharmacology, and cannabinoid agonists.

Publications per year

2002–2010

Publications

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Douglas Osei‐Hyiaman, Michael A. DePetrillo, Pál Pacher et al. · Journal of Clinical Investigation · 2005 · 985 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Douglas Osei‐Hyiaman, Michael A. DePetrillo, Pál Pacher et al. · Journal of Clinical Investigation · 2005 · 920 citations

Life Sciences, Biochemistry, Pharmacology +17

Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension

Sándor Bátkai, Pál Pacher, Douglas Osei‐Hyiaman et al. · Circulation · 2004 · 322 citations · Full text

Medicine, Cardiology, Pharmacology +14

<i>N</i> -arachidonoyl <scp>l</scp> -serine, an endocannabinoid-like brain constituent with vasodilatory properties

Garry Milman, Yehoshua Maor, Saleh Abu‐Lafi et al. · Proceedings of the National Academy of Sciences · 2006 · 186 citations · Full text

Medicine, Neurobiology, Pharmacology +15

Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic Effects

Grzegorz Godlewski, Shakiru O. Alapafuja, Sándor Bátkai et al. · Chemistry & Biology · 2010 · 94 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

1–5 of 11